Somatostatin regulates brain amyloid β peptide Aβ42 through modulation of proteolytic degradation

Takashi Saito, Nobuhisa Iwata, Satoshi Tsubuki, Yoshie Takaki, Jiro Takano, Shu Ming Huang, Takahiro Suemoto, Makoto Higuchi, Takaomi C. Saido

研究成果: ジャーナルへの寄稿学術論文査読

321 被引用数 (Scopus)

抄録

Expression of somatostatin in the brain declines during aging in various mammals including apes and humans. A prominent decrease in this neuropeptide also represents a pathological characteristic of Alzheimer disease. Using in vitro and in vivo paradigms, we show that somatostatin regulates the metabolism of amyloid β peptide (Aβ), the primary pathogenic agent of Alzheimer disease, in the brain through modulating proteolytic degradation catalyzed by neprilysin. Among various effector candidates, only somatostatin upregulated neprilysin activity in primary cortical neurons. A genetic deficiency of somatostatin altered hippocampal neprilysin activity and localization, and increased the quantity of a hydrophobic 42-mer form of Aβ, Aβ42, in a manner similar to presenilin gene mutations that cause familial Alzheimer disease. These results indicate that the aging-induced downregulation of somatostatin expression may be a trigger for Aβ accumulation leading to late-onset sporadic Alzheimer disease, and suggest that somatostatin receptors may be pharmacological-target candidates for prevention and treatment of Alzheimer disease.

本文言語英語
ページ(範囲)434-439
ページ数6
ジャーナルNature Medicine
11
4
DOI
出版ステータス出版済み - 04-2005
外部発表はい

All Science Journal Classification (ASJC) codes

  • 生化学、遺伝学、分子生物学一般

フィンガープリント

「Somatostatin regulates brain amyloid β peptide Aβ42 through modulation of proteolytic degradation」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル